MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Receives FDA Breakthrough Device Designation for At-Home Heart Attack Assessment
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
News headline image
BBNX Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Beta Bionics, Inc.
Via Newsfile
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.
Via Newsfile
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox is Investigating Possible Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Alerts Investors: Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is Under Investigation for Potential Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Understanding How ‘Biosimilar’ Drugs Can Expand Access and Affordability
Via StatePoint Media
Exposures Product Safety
News headline image
Invivyd’s VYD2311 Phase III Study Meets Safety Goals, Eyes FDA Accelerated Approval ↗
Via MarketBeat
Tickers ARM IVVD
Exposures COVID-19 Product Safety
News headline image
PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data ↗
Via MarketBeat
Topics Bonds
Tickers PYPD
Exposures Debt Markets Product Safety
News headline image
Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years? ↗
Via The Motley Fool
Tickers GRAL
Exposures Product Safety
News headline image
Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing ↗
Via MarketBeat
Tickers RFL
Exposures Product Safety
News headline image
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think. ↗
Via The Motley Fool
Topics Intellectual Property
Tickers ABBV
Exposures Intellectual Property Product Safety
News headline image
Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment ↗
Via MarketBeat
Tickers AMLX
Exposures Product Safety
News headline image
Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea — General Debate under Item 3, 63rd session of the Human Rights Council
Via 24-7 Press Release
Topics Product Recall Religion
Exposures Legal Product Safety Religion
News headline image
Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) With Significant Losses to a Securities Class Action Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
NetworkNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Positions SSi Mantra for Next Phase of Expansion
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
Kaplan Fox Class Action Reminder: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Lead Plaintiff Deadline is November 2, 2026
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
News headline image
Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision ↗
Via MarketBeat
Tickers CLNN
Exposures Product Safety
News headline image
Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup ↗
Via MarketBeat
Tickers INBX
Exposures Product Safety
News headline image
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors Who Suffered Losses to a Securities Class Action - Deadline is November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to Contact the Firm Regarding Potential Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) and Its Officers for Potential Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
OS Therapies Appoints Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer
Via Newsfile
Tickers OSTX
Exposures Product Safety
News headline image
PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform
Via Newsfile
Tickers CSE:PHRM PHRRF
Exposures Product Safety
News headline image
$11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression Greatly Expands Application Potential for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Intellectual Property
Tickers NRXP
Exposures Intellectual Property Product Safety
News headline image
Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea — General Debate under Item 3, 63rd session of the Human Rights Council
Via 24-7 Press Release
Topics Product Recall Religion
Exposures Legal Product Safety Religion
News headline image
Pre-trial Detention of Chairman Lee Man-hee Brought Before UN Human Rights Council
Via 24-7 Press Release
Topics Product Recall Religion
Exposures Legal Product Safety Religion
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Contact the Firm Before November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
$11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
Via PRLog
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story